Search results
The growing promise of cancer vaccines
Cosmos· 21 hours agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 3 days agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
Research identifies an infectious language epidemic
Digital Journal· 1 day agoWhat effects did social media rhetoric have on COVID-19 infection and death rates across the U.S., and what can policymakers and public health officials...
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 8 hours agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine ...
The Heroes Of Vaccine Development: Lipid Nanoparticles
BioresearchOnline· 12 hours agoLipid nanoparticles (LNPs) have played a crucial role in the advancement of vaccine development,...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 7 days agoPfizer and BioNTech were sued by Moderna in 2022. It accused them of using its patented mRNA...
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 3 days agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...